Medicare Enrolled

Dr. Yamil Fourzali Sabbag, M.D.

Nuclear Medicine · Fort Myers, FL
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
14551 HOPE CENTER LOOP STE 100, Fort Myers, FL 33912
2399362316
In practice since 2007 (18 years)
NPI: 1881876936 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fourzali Sabbag from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fourzali Sabbag? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fourzali Sabbag

Dr. Yamil Fourzali Sabbag is a nuclear medicine in Fort Myers, FL, with 18 years in practice. Based on federal Medicare data, Dr. Fourzali Sabbag performed 13,496 Medicare services across 4,280 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fourzali Sabbag received a total of $241 from 5 pharmaceutical and/or device companies across 6 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fourzali Sabbag is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 40% volume in FL$ $241 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,496
Medicare services
Top 40% in FL for nuclear medicine
4,280
Unique beneficiaries
$181
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~750 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
MRI contrast dye injection (gadoterate)5,631$0$2
Contrast dye for imaging (iodine-based)2,145$0$1
Piflufolastat f-18, diagnostic, 1 millicurie1,346$424$557
Nuclear medicine study from skull base to mid-thigh with ct scan1,117$761$2,644
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries525$401$690
Electrocardiogram (EKG), 12-lead385$11$74
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries240$28$63
Nuclear medicine study of bone and/or joint whole body224$189$560
Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging208$250$723
Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries156$2,130$3,488
Technetium tc-99m sestamibi, diagnostic, per study dose110$89$175
Regadenoson injection (Lexiscan) for heart stress test92$46$73
Nuclear medicine study of stomach to assess emptying77$193$411
Nuclear medicine study of liver and bile duct system69$224$594
Nuclear medicine study of bone taken at different times68$242$627
EKG interpretation and report68$6$21
Nuclear medicine study whole body with ct scan67$927$3,317
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries64$7$64
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries59$64$96
Nuclear medicine study of kidney, blood, flow, and function with drug administration56$126$555
Mri scan of lower spinal canal without contrast54$98$1,322
Copper cu-64, dotatate, diagnostic, 1 millicurie52$752$1,031
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician50$49$319
Injection, furosemide, up to 20 mg49$0$8
Nuclear medicine study of parathyroid with spect46$230$807
Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries42$18$182
Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries41$254$772
Nuclear medicine study of lung ventilation and circulation36$246$611
Nuclear medicine study limited area with ct scan35$1,064$3,475
Echocardiogram, transthoracic35$100$319
CT scan of chest, without contrast34$87$785
Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries33$106$151
Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries32$85$115
Nuclear medicine studies of heart muscle at rest and with stress and spect30$344$776
Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries30$2,195$2,800
Nuclear medicine study of brain with metabolic evaluation23$612$2,322
Mri scan of upper spinal canal without contrast21$86$1,197
Mri scan of leg joint without contrast21$112$1,116
Nuclear medicine study of thyroid and thyroid function20$146$315
3D screening mammography (tomosynthesis)19$24$44
Screening mammography19$92$199
Low dose ct scan of chest for lung cancer screening17$135$368
Mri scan of brain without contrast14$100$1,190
Mri scan of brain before and after contrast13$158$2,642
Routine electrocardiogram (ecg) using at least 12 leads with tracing12$3$56
Nuclear medicine study, 1 area11$159$450
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
75.8% medium
24.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$241
Total received (2021-2024)
Avg $80/year across 3 years
Top 39% in FL for nuclear medicine
5
Companies
6
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$241 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$124
2023
$21
2021
$96

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PROGENICS PHARMACEUTICALS, INC.
$82
GE HEALTHCARE
$66
RefleXion Medical, Inc.
$42
Progenics Pharmaceuticals, Inc.
$30
Blue Earth Diagnostics Limited
$21
Top 3 companies account for 78.8% of total payments
Associated products mentioned in payments ›
POSLUMA · PYLARIFY · REFLEXION MEDICAL RADIOTHERAPY SYSTEM
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a nuclear medicine in Fort Myers?
Compare nuclear medicines in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse nuclear medicines nearby

Geographic Context

Nuclear Medicines within 10 mi
3
Per 100K population
0.4
County median income
$73,099
Nearest hospital
GULF COAST MEDICAL CENTER LEE HEALTH
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Fourzali Sabbag is a cardiac imaging specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Fourzali Sabbag experienced with mri contrast dye injection (gadoterate)?
Based on Medicare claims data, Dr. Fourzali Sabbag performed 5,631 mri contrast dye injection (gadoterate) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fourzali Sabbag receive payments from pharmaceutical companies?
Yes. Dr. Fourzali Sabbag received a total of $241 from 5 companies across 6 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fourzali Sabbag's costs compare to other nuclear medicines in Fort Myers?
Dr. Fourzali Sabbag's average Medicare payment per service is $181. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fourzali Sabbag) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →